The Utility of Mitochondrial Detection Methods Applied as an Additional Tool for the Differentiation of Renal Cell Tumors
暂无分享,去创建一个
S. Despotović | M. Životić | Sanja Radojević Škodrić | D. Dundjerović | S. Cirović | Gorana Nikolic | Gorana Nikolić
[1] C. Hoyt,et al. Companion diagnostic requirements for spatial biology using multiplex immunofluorescence and multispectral imaging , 2023, Frontiers in Molecular Biosciences.
[2] I. Meinhold-Heerlein,et al. Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy , 2023, International journal of molecular sciences.
[3] M. Rubin,et al. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2022, European urology.
[4] A. Aguilar-Vázquez,et al. Ten Approaches That Improve Immunostaining: A Review of the Latest Advances for the Optimization of Immunofluorescence , 2022, International journal of molecular sciences.
[5] J. Cheville,et al. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia , 2021, Modern Pathology.
[6] Yuehua Wu,et al. Sporadic Oncocytic Tumors with Features Intermediate between Oncocytoma and Chromophobe Renal Cell Carcinoma: Comprehensive Clinico-Pathological and Genomic Profiling , 2020, medRxiv.
[7] W. Yong,et al. An Introduction to Performing Immunofluorescence Staining. , 2018, Methods in molecular biology.
[8] Dijana Cerjan,et al. Characteristics of the tissue section that influence the staining outcome in immunohistochemistry , 2018, Histochemistry and Cell Biology.
[9] S. Nasr,et al. Paraffin Immunofluorescence: A Valuable Ancillary Technique in Renal Pathology , 2018, Kidney international reports.
[10] N. Golić,et al. The Role of Macrophage Migration Inhibitory Factor in the Function of Intestinal Barrier , 2018, Scientific Reports.
[11] A. Wu. Oncocytic Renal Neoplasms on Resections and Core Biopsies: Our Approach to This Challenging Differential Diagnosis. , 2017, Archives of pathology & laboratory medicine.
[12] B. Delahunt,et al. Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. , 2017, Human pathology.
[13] Chan-Sik Park,et al. Immunohistochemistry for Pathologists: Protocols, Pitfalls, and Tips , 2016, Journal of pathology and translational medicine.
[14] I. Zaletel,et al. Expression of p300 and p300/CBP associated factor (PCAF) in actinic keratosis and squamous cell carcinoma of the skin. , 2016, Experimental and molecular pathology.
[15] E. White,et al. Mitochondria and Cancer. , 2016, Molecular cell.
[16] S. Truchet,et al. Indirect Immunofluorescence on Frozen Sections of Mouse Mammary Gland. , 2015, Journal of visualized experiments : JoVE.
[17] P. Walker,et al. Paraffin immunofluorescence in the renal pathology laboratory: more than a salvage technique , 2015, Modern Pathology.
[18] D. Lindgren,et al. Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate , 2015, Cell Death and Disease.
[19] M. Oya,et al. Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors , 2013, Medical Molecular Morphology.
[20] M. Yusenko. Molecular pathology of chromophobe renal cell carcinoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.
[21] M. Selig,et al. Use of Electron Microscopy in Core Biopsy Diagnosis of Oncocytic Renal Tumors , 2010, Ultrastructural pathology.
[22] M. Scialpi,et al. Electron microscopy: the gold standard in the differential diagnosis of chromophobe renal cell carcinoma and oncocytoma. , 2010, Analytical and quantitative cytology and histology.
[23] S. Singh,et al. Sub-typing of renal cell tumours; contribution of ancillary techniques , 2009, Diagnostic pathology.
[24] M. Gulluoglu,et al. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis , 2005, Virchows Archiv.
[25] P. Tamboli,et al. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray , 2004, Histopathology.
[26] S. Tickoo,et al. Ultrastructural Observations on Mitochondria and Microvesicles in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Eosinophilic Variant of Conventional (Clear Cell) Renal Cell Carcinoma , 2000, The American journal of surgical pathology.
[27] S. Tickoo,et al. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors. , 1997, The American journal of surgical pathology.
[28] S. Störkel,et al. The human chromophobe cell renal carcinoma: Its probable relation to intercalated cells of the collecting duct , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.
[29] K. Mai,et al. Chromophobe cell carcinoma and renal cell neoplasms with mucin-like changes. , 2000, Acta histochemica.